ロード中...
Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis
Biktarvy (bictegravir/emtricitabine/tenofovir alafemanide), which has been recently approved for the treatment of HIV, is a single-pill regimen that associates bictegravir and a novel integrase strand transfer inhibitor (INSTI) with a combination of two nucleoside reverse transcriptase inhibitors (N...
保存先:
| 出版年: | BMJ Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7332188/ https://ncbi.nlm.nih.gov/pubmed/32611654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-234483 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|